Skip to content

Clinical trials

Withdrawn Phase 2 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Withdrawn Country / region: Netherlands Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20134
20141
20151
20161
20182
20191
20201
20213
20222
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Erasmus Medical Center2
Maastricht Radiation Oncology2
AbbVie1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
AstraZeneca1
Bayer1
Borstkanker Onderzoek Groep1
Bristol-Myers Squibb1
Crucell Holland BV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms4
Breast Neoplasms3
Neoplastic Cells, Circulating2
Anemia, Refractory, with Excess of Blasts1
Anemia, Sickle Cell1
Arthritis, Rheumatoid1
Carcinoma, Non-Small-Cell Lung1
Colitis, Ulcerative1
Cystic Fibrosis1
Diabetes Mellitus, Type 11

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.